Transcutaneous Bilirubinometers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

The transcutaneous bilirubinometers market is expected to register a CAGR of 6.0% during the forecast period.

The COVID-19 pandemic had a significant impact on the market studied. Due to the emergence of COVID-19, governments of countries across the globe took measures to aid the infection globally. Since neonatal jaundice screening necessitates the presence of both parents in the hospital, the spread of infection is increased. As a result, a few countries implemented COVID-19 control measures, such as providing neonate jaundice screening services outside of hospitals and clinics. For instance, as per an article published in the Journal of Pediatrics and Child Health in January 2021, during the initial phase of the pandemic, the Malaysian Ministry of Health introduced the transcutaneous bilirubin drive-through (DT) service to reduce congestion in hospitals. This increased the demand for transcutaneous bilirubinometers. Additionally, in the later phases of the pandemic, demand for transcutaneous bilirubin tests increased, owing to an increase in jaundice cases among the neonate population. This created demand for transcutaneous bilirubinometers and significantly propelled the market growth. Thus, owing to the factors mentioned above, the pandemic impacted the market studied significantly and is expected to witness growth over the forecast period.

Factors such as the rising incidence of jaundice in neonatal patients and technological advancements greatly contribute to the studied market's growth.

Neonatal jaundice is a frequent source of concern for parents and caregivers. It can cause serious problems, including bilirubin encephalopathy if ignored. The condition is very common among neonates globally. As per the August 2022 update of the NCBI data, nearly 60% of term and 80% of preterm newborns develop clinical jaundice in the first week after birth. Additionally, as per the source above, most newborns with clinical jaundice have unconjugated hyperbilirubinemia (UHB), but conjugated hyperbilirubinemia (CHB), which is invariably abnormal and indicates an underlying medical reason, is present in some newborns with jaundice. Thus, this high risk of jaundice among neonates is creating demand for bilirubin tests. Thus, the demand for transcutaneous bilirubinometers is increasing, driving the market's growth.

Furthermore, neonatal jaundice is a temporary and physiological accumulation of bilirubin that causes the majority of neonatal jaundice, which is a common condition among newborn babies. Neonatal hyperbilirubinemia may become extreme in a small percentage of infants, which could ultimately result in brain damage.

In addition, despite being a condition that can be avoided, there have been some reports of an increase in the incidence of debilitating newborn hyperbilirubinemia. Thus, guidelines have been issued for the screening and management of neonatal hyperbilirubinemia, and the demand for transcutaneous bilirubin tests has increased. According to an article published in the Springer Nature journal in April 2022, non-invasive, transcutaneous bilirubin screenings have become widely used as first-line screening tools in high-resource settings to avoid uncomfortable blood sampling and obtain a speedy result at the bedside. Thus, with an increased risk of jaundice among neonates, the demand for transcutaneous bilirubinometers is increasing. This is further driving the studied market's growth.

Therefore, the factors mentioned above, such as the rise in neonatal jaundice cases, are predicted to contribute to the growth of the studied market over the forecast period. However, the high cost of tests is expected to hamper the market growth.

Transcutaneous Billirubinometers Market Trends

Portable Segment is Expected to Witness a Healthy Growth Over the Forecast Period

Portable transcutaneous jaundice meters offer an easy and quick method for ongoing assessment to identify abnormal bilirubin levels. As portable devices are easily movable from one place to another and easy to handle, demand for such devices is increasing. This is expected to contribute to segment growth.

A few portable transcutaneous bilirubin meters are currently being developed for accurate and low-cost bilirubin monitoring. The handheld jaundice detector BM-100 Series, developed in China for transcutaneous jaundice detection, can store multiple patient information at the same time and convert between two measurement units (mg/dL and mol/L).

In addition, according to the 2022 update by Delta Medical International, the MBJ20 jaundice meter is simple to apply and operate, quick, and easy to obtain bilirubin readings with minimal disturbance to the neonate. Also, the product has a compact, ergonomic design that makes it easy to hold, with a display that is easy to read and very convenient to carry. In addition, as per the source above, the use of these portable transcutaneous bilirubinometers helps in determining bilirubin levels instantly and non-invasively by the healthcare professional and the patient both. Thus, due to the availability of such products in the market, the studied segment is anticipated to witness growth over the forecast period.

Asia-Pacific is Expected to Grow at a Fastest Growth Rate Over the Forecast Period

Asia-Pacific holds a significant share of the market, and it is expected to grow at the fastest rate over the analysis period. Owing to increased cases of neonatal jaundice across the countries of the region, the market is expected to witness growth over the forecast period.

During the newborn stage, hyperbilirubinemia-related jaundice is a frequent occurrence. The incidence and prevalence of the disease are increasing among the neonate population in the countries of the Asia-Pacific region, such as China and South Korea, among others. As per an article published in the TP journal, in June 2022, when researchers in China observed the relationship between exposure factors and neonatal hyperbilirubinemia, they concluded that exclusive breastfeeding, G6PD (glucose-6-phosphate dehydrogenase) deficiency, and premature birth are major risk factors for neonatal jaundice in China.

In addition, according to an article published in the BMJ journal in August 2022, when a study was conducted in a public hospital in China, the new mothers were found to have a lack of knowledge about neonatal jaundice, especially breast milk jaundice. Thus, the researchers of the study recommended improving maternal information-seeking behavior about neonatal jaundice in China. Thus, such instances increase the risk of neonatal jaundice incidence in the region, which creates demand for bilirubin tests. As transcutaneous bilirubin tests are a major accomplishment for bilirubin tests, this creates opportunities for the introduction of newer products by the transcutaneous bilirubinometer manufacturers in the region, further fueling the market's growth.

Therefore, owing to these factors, the studied market is expected to witness growth in the Asia-Pacific region over the forecast period.

Transcutaneous Billirubinometers Market Competitor Analysis

The transcutaneous bilirubinometers market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Merck KGaA, Sartorius AG, Meissner Filtration Products Inc., ThermoFisher Scientific Inc., Donaldson Company, Parker Hannifin Corp., Eaton Corporation PLC, Pall Corporation, 3M, and Filter Integrity Ltd., among others.

Additional benefits of purchasing the report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.